The influence of interleukin-6 and tumor necrosis factor α gene polymorphisms on bone mineral density in postmenopausal women;Wpływ polimorfizmu genu interleukiny-6 i czynnika martwicy nowotworu α na gestość mineralna kości kobiet po menopauzie

Ginekologia Polska

Volumn 79, Issue 6, 2008, Pages 426-431

  Kusek, Justyna ^a   Seremak Mrozikiewicz, Agnieszka ^b   Drews, Krzysztof ^b   Mikołajczak, Przemysław ^c   Czerny, Bogusław ^d   Maciejewska, Monika ^a   Bogacz, Anna ^a   Derebecka Hołysz, Natalia ^a   Barlik, Magdalena ^e   Mrozikiewicz, Przemysław M ^a  

^a Instytut Ro lin i Przetworów Zielarskich w Poznaniu   (Poland)

^b Katedra i Klinika Perinatologii   (Poland)

^c Uniwersytetu Medycznego   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

^e Katedra Zdrowia Matki I Dziecka Uniwersytetu Medycznego Im Karola Marcinkowskiego W Poznaniu   (Poland)

Author keywords

Bone mineral density; Genetic polymorphism; Interleukin 6; Osteoporosis; Tumor necrosis factor alpha

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE DENSITY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; LUMBAR VERTEBRA; MIDDLE AGED; PHOTON ABSORPTIOMETRY; POLAND; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RADIOGRAPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; FEMALE; HUMANS; INTERLEUKIN-6; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLAND; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTMENOPAUSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48849106479     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ralston S. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab. 2002, 87, 2460-2466.
2. Thakkinstian A, D'Este C, Eisman J, [et al.]. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004, 19, 419-428.
3. Seremak-Mrozikiewicz A, Drews K, Dańska A, [et al.]. Polimorfizm genu kodujacego receptor witaminy D w grupie kobiet w okresie pomenopauzalnym z niska gestościa mineralna kości. Ginekol Pol. 2004, 75, 367-372.
4. Drews K, Seremak-Mrozikiewicz A, Bartkowiak-Wieczorek J, [et al.]. Polimorfizm genetyczny receptora estrogenowego alfa-czynnik ryzyka osteoporozy? Ginekol Pol. 2006, 77, 72-78.
5. Horst-Sikorska W, Kalak R, Wawrzyniak A, [et al.]. Association analysis of the polymorphisms of the VDR gene with bone mineral density and the occurrence of fractures. J Bone Miner Metab. 2007, 25, 310-319.
6. Rachoń D. Rola czynnika martwicy nowotworu i interleukiny 6 w patogenezie póznych nastepstw menopauzy. Wpływ hormonalnej terapii zastepczej na ich ekspresje. Pol Merkur Lekarski. 2005, 17, 724-727.
7. Pfeilschifter J, Koditz R, Pfohl M, [et al.]. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002, 23, 90-119.
8. Manolagas S. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000, 21, 115-137.
9. Mundy G. Osteoporosis and inflammation. Nutr Rev. 2007, 65, 147-151.
10. Ferrari S, Karasik D, Liu J, [et al.]. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women form the Framingham Osteoporosis Study. J Bone Miner Res. 2004, 19, 552-559.
11. Abraham L, Kroeger K. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999, 66, 562-566.
12. Terry C, Loukaci V, Green F. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000, 275, 24, 18138-18144.
13. Haddy N, Sass C, Maumus S, [et al.]. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet. 2005, 13, 109-117.
14. Hegedus C, Skibola C, Bracci P, [et al.]. Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G/C polymorphism. Proteomics. 2007, 7, 548-557.
15. Fishman D, Faulds G, Jeffery R, [et al.]. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998, 102, 1369-1376.
16. Bouma G, Crusius J, Oudkerk Pool M, [et al.]. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol. 1996, 43, 456-463.
17. Garnero P, Sornay-Rendu E, Duboeuf F, [et al.]. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res. 1999, 14, 1614-1621.
18. Kalak R, Horst-Sikorska W, Słomski R. Podłoże genetyczne osteoporozy. Aktualny stan badań. Postepy Biologii Komńrki. 2000, 27, 53-71.
19. Lorentzon M, Lorentzon R, Nordström P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res. 2000, 15, 1944-1949.
20. Herrmann S, Ricard S, Nicaud V, [et al.]. Polymorphisms of the tumor necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest. 1998, 28, 59-66.
21. Wennberg P, Nordstrom P, Lorentzon R, [et al.]. TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol. 2002, 146, 629-634.
22. Chen H, Chen W, Hsu C, [et al.]. Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol. 2005, 122, 73-78.
23. Parfitt A. Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical consequences. Calcif Tissue Int. 1984, 36, Suppl 1, 123-128.